Anti-Diabetic Effects of Jiang Tang Xiao Ke Granule via PI3K/Akt Signalling Pathway in Type 2 Diabetes KKAy Mice

作者：Yu, Na; Fang, Xin; Zhao, Dandan; Mu, Qianqian; Zuo, Jiacheng; Ma, Yue; Zhang, Yi; Mo, Fangfang; Zhang, Dongwei; Jiang, Guangjian; Wu, Rui; Gao, Sihua^*

来源：PLos One, 2017, 12(1): e0168980.

DOI：10.1371/journal.pone.0168980

• MUSCLE INSULIN-RESISTANCE
• TRADITIONAL CHINESE MEDICINE
• BETA-CELL DYSFUNCTION
• GLUCOSE-UPTAKE
• 3T3-L1 ADIPOCYTES
• FATTY-ACIDS
• PPAR-GAMMA
• TRANSLOCATION
• OBESITY
• EXPRESSION

Jiang Tang Xiao Ke (JTXK) granule, a Chinese herbal formula, has been used clinically to treat type 2 diabetes (T2DM) for decades. Our previous studies showed that JTXK granule exhibited anti-diabetic and anti-oxidative functions in experimental diabetic rats induced by a high fat diet and streptozotocin. However, the underlying mechanisms remain poorly understood. Herein, we aimed to investigate the therapeutic effect of JTXK granule on T2DM KKAy mice and the possible associations with skeletal muscle in the current study. Our results showed that JTXK granule significantly reduced food intake and body weight in T2DM KKAy mice. JTXK granule treatment also decreased the blood glucose and HbA1c levels and increased the insulin sensitivity in a time-dependent manner. Additionally, it ameliorated hyperlipidaemia and induced a lower free fatty acid level, displaying an effect on disorders of lipid metabolism. JTXK granule significantly increased the expression of insulin receptor substrate-1 (IRS-1), phosphoinositide 3-kinase (PI3K), protein kinase B (PKB/Akt) and glucose transporter 4 (Glut4) and decreased the expression of glycogen synthase kinase 3 beta (GSK3 beta). We concluded that JTXK granule is an effective drug for T2DM through regulating the PI3K/Akt signalling pathway in skeletal muscle.

• 出版日期2017-1-3
• 单位中国中医科学院广安门医院; 北京中医药大学